ProstateExtra
ProstateExtra, licence 80033570: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Natural Equivalents Incorporated
- NPN or DIN-HM
- 80033570
- Status
- Active licence
- Licence date
- 11 July 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zea mays Source : Pollen Potency : 7.0 % Phytosterols | 0.18 mg | Not calculated |
| phytostérols Source : Glycine max - Graine Potency : 40.0 % Beta-sitosterol | 12.5 mg | Not calculated |
| Cucurbita pepo Source : Huile de graines | 20.0 mg | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 11.25 mg AT | Not calculated |
| Vitamine E Source : Acétate de d-alpha tocophéryle | 25.0 UI | Not calculated |
| Secale cereale Source : Pollen Potency : 6.0 % Amino Acids | 3.6 mg | Not calculated |
Non-medicinal ingredients
Phosphate de calcium, monobasique, Stéarate de magnésium, Microcrystalline cellulose, Maltodextrine, Stéarate de calcium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) and help reduce difficulty in urination associated with mild to moderate benign prostatic hyperplasia. Antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80033570
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.